Page 148 | Certara

Publication

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…

CertaraFebruary 9, 2021

On-Demand Webinar

RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing

Narratives are an integral part of medical writing. Sponsors sometimes need to prepare large…

CertaraFebruary 8, 2021

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

CertaraFebruary 3, 2021

Blog

8 Tips for Successfully Developing Oligonucleotide Therapies

By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…

CertaraFebruary 1, 2021

Brochure

BaseCase Interactive for Medical Affairs

CertaraJanuary 28, 2021

Brochure

Simcyp® PBPK Simulator

Streamlines drug development by using PBPK modeling to predict drug behavior in virtual populations, optimize…

CertaraJanuary 22, 2021

On-Demand Webinar

How drug developers can avoid these common mistakes to secure a deal

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

CertaraJanuary 21, 2021

On-Demand Webinar

Making your biotech program investor-ready

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

CertaraJanuary 21, 2021

On-Demand Webinar

An Introduction to Asset Evaluation for Emerging Biotech Companies

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

CertaraJanuary 21, 2021

White Paper

“Where do I start?”: Strategies for selecting the first dose for human clinical trials

This guide to dose selection for first-in-human studies explains the conceptual framework, methods, and tools…

CertaraDecember 22, 2020

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

8 Tips for Successfully Developing Oligonucleotide Therapies

BaseCase Interactive for Medical Affairs

Simcyp® PBPK Simulator

How drug developers can avoid these common mistakes to secure a deal

Making your biotech program investor-ready

An Introduction to Asset Evaluation for Emerging Biotech Companies

“Where do I start?”: Strategies for selecting the first dose for human clinical trials

Newsletter sign up

Quick links

Solutions

Contact